Q5131

Injection, adalimumab-aacf (idacio), biosimilar, 20 mg

TerminatedHCPCS Level II code.

Still listed by CMS but carries a termination date, so it is not valid for a current date of service.

Terminated with effect from 2024-12-31. First published 2023. CMS still lists this code in the current quarterly file - it carries a termination date rather than being removed.

What has happened to this code

Every change the publisher made, from 2023 to now.

July 2023 Added to the code set Injection, adalimumab-aacf (idacio), biosimilar, 20 mg
January 2025 Terminated by CMS